Prof. Dr. Markus Neurath

Lehrstuhl für Innere Medizin I (Medizin 1)

A spotlight on intestinal permeability and inflammatory bowel diseases (2023) Rath T, Atreya R, Neurath M Journal article, Review article IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling (2023) Chiriac MT, Hracsko Z, Günther C, Gonzalez Acera M, Atreya R, Stolzer I, Wittner L, et al. Journal article NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases (2023) Weber S, Sitte S, Vögele AL, Sologub L, Wilfer A, Rath T, Nägel A, et al. Journal article Healing of the epithelial barrier in the ileum is superior to endoscopic and histologic remission for predicting major adverse outcomes in ulcerative colitis (2023) Rath T, Atreya R, Bodenschatz J, Uter W, Geppert CI, Vitali F, Zundler S, et al. Journal article IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells. (2023) Ullrich K, Derdau J, Baltes C, Battistella A, Rosso G, Uderhardt S, Schulze L, et al. Journal article Further efficacy and safety data for maintenance upadacitinib in ulcerative colitis (2023) Atreya R, Neurath M Journal article Endoscopic Ultrasound in Pancreatology: Focus on Inflammatory Diseases and Interventions (2023) Vitali F, Zundler S, Jesper D, Strobel D, Wildner D, De Pretis N, Frulloni L, et al. Journal article, Review article Novel T cell/organoid culture system allows ex vivo modeling of intestinal graft-versus-host disease (2023) Matthe D, Dinkel M, Schmid B, Vogler T, Neurath M, Poeck H, Neufert C, et al. Journal article Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing (2023) Neurath M, Vieth M Journal article, Review article Protective effect of the novel calcineurin inhibitor voclosporin in experimental colitis (2023) Lindemann A, Roth D, Koop K, Neufert C, Zundler S, Atreya R, Neurath M, Leppkes M Journal article